Neuroendocrine responses as a probe into the mechanisms of action of electroconvulsive therapy.
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000929:Antidepressive Agents, Tricyclic / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology*; D003000:Clonidine / Q000494:pharmacology*; D004565:Electroconvulsive Therapy; D004597:Electroshock; D013006:Growth Hormone / Q000378:metabolism; D006728:Hormones / Q000378:metabolism*; D006801:Humans; D011388:Prolactin / Q000378:metabolism; D051381:Rats; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology
D000929:Antidepressive Agents, Tricyclic; D006728:Hormones; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine; D011388:Prolactin; D013006:Growth Hormone; D000661:Amphetamine; D003000:Clonidine; D001058:Apomorphine